Vigo has been appointed by VarmX, a Netherlands-based biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, to support its growth strategy through corporate and industry profile raising and media relations.
Vigo has been appointed by VarmX, a Netherlands-based biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, to support its growth strategy through corporate and industry profile raising and media relations.